# Chronic Fatigue Syndrome/Myalgic Encephalomyelitis:  Developing Drug Products for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/chronic-fatigue-syndromemyalgic-encephalomyelitis-developing-drug-products-for-treatment/1a25a9e8-1852-4b92-8380-feaa374b8e13

> FDA guidance document: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis:  Developing Drug Products for Treatment. Issue date: March 11, 2014. Get complete insights and analysis.

---

## Details

- Title: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis:  Developing Drug Products for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2014-03-11
- Last Changed: 2021-01-26
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-0264 ">FDA-2014-D-0264 </a>

## Related Documents

- [Migraine:  Developing Drugs for Preventive Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-preventive-treatment/cd739d7c-f8ed-4a37-b16f-d6f3b9550a94)
- [Alcoholism:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/alcoholism-developing-drugs-for-treatment/5dd607ce-ea00-4415-bc0a-e05b7963322b)
- [Endogenous Cushing’s Syndrome: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/endogenous-cushings-syndrome-developing-drugs-for-treatment/c89a914f-8df3-4543-87dc-697dcbc10611)